Premium
Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia
Author(s) -
Young Lawrence H.,
Henderson Katharine J.,
White Robert I.,
GarciaTsao Guadalupe
Publication year - 2013
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.26472
Subject(s) - medicine , bevacizumab , cardiac index , telangiectasia , context (archaeology) , cardiology , vascular endothelial growth factor , surgery , gastroenterology , cardiac output , chemotherapy , blood pressure , vegf receptors , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom